Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Schollmeyer

Showing results (81-90 of 288) with videos related to

Pageof 29
Sort By:
European Journal of Pharmacology|November 14, 1994
Oxidized lipoprotein(a) inhibits endothelium-dependent dilation: prevention by high density lipoproteinJ Galle, J Bengen, P Schollmeyer, et al.
Mineral and Electrolyte Metabolism|January 1, 1990
Failure to detect remarkable hypomagnesemia in renal transplant recipients receiving ciclosporinM Haag-Weber, P Schollmeyer, W H Hörl
Kidney & Blood Pressure Research|January 1, 1996
Arginine vasopressin and oxytocin increase intracellular calcium and cAMP in human glomerular epithelial cells in cultureM Späth, H Pavenstädt, J Petersen, et al.
Nephron|January 1, 1995
Clinical course of patients with antineutrophil cytoplasm antibody positive vasculitis after kidney transplantationW Grotz, C Wanner, E Röther, et al.
Circulation|September 15, 1995
Impairment of endothelium-dependent dilation in rabbit renal arteries by oxidized lipoprotein(a). Role of oxygen-derived radicalsJ Galle, J Bengen, P Schollmeyer, et al.
European Journal of Clinical Investigation|August 1, 1988
Granulocyte activation during haemodialysis in the absence of complement activation: inhibition by calcium channel blockersM Haag-Weber, P Schollmeyer, W H Hörl
Contributions to Nephrology|January 1, 1991
Effect of human recombinant erythropoietin on dialysis efficiency in CAPDH B Steinhauer, I Lubrich-Birkner, P Schollmeyer
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1996
Elevated lipoprotein(a) and fibrinogen levels [corrected] increase the cardiovascular risk in continuous ambulatory peritoneal dialysis patientsW Bartens, M Nauck, P Schollmeyer, et al.
Hypertension (Dallas, Tex. : 1979)|March 1, 1993
Cyclosporine and oxidized lipoproteins affect vascular reactivity. Influence of the endotheliumJ Galle, I Schenck, P Schollmeyer, et al.
Transplantation Proceedings|September 2, 1998
Drug monitoring of mycophenolic acid in the early period after renal transplantationB Krumme, K Wollenberg, G Kirste, et al.
Pageof 29

Showing results (81-90 of 288) with videos related to

Sort By:
Pageof 29
European Journal of Pharmacology|November 14, 1994
Oxidized lipoprotein(a) inhibits endothelium-dependent dilation: prevention by high density lipoproteinJ Galle, J Bengen, P Schollmeyer, et al.
Mineral and Electrolyte Metabolism|January 1, 1990
Failure to detect remarkable hypomagnesemia in renal transplant recipients receiving ciclosporinM Haag-Weber, P Schollmeyer, W H Hörl
Kidney & Blood Pressure Research|January 1, 1996
Arginine vasopressin and oxytocin increase intracellular calcium and cAMP in human glomerular epithelial cells in cultureM Späth, H Pavenstädt, J Petersen, et al.
Nephron|January 1, 1995
Clinical course of patients with antineutrophil cytoplasm antibody positive vasculitis after kidney transplantationW Grotz, C Wanner, E Röther, et al.
Circulation|September 15, 1995
Impairment of endothelium-dependent dilation in rabbit renal arteries by oxidized lipoprotein(a). Role of oxygen-derived radicalsJ Galle, J Bengen, P Schollmeyer, et al.
European Journal of Clinical Investigation|August 1, 1988
Granulocyte activation during haemodialysis in the absence of complement activation: inhibition by calcium channel blockersM Haag-Weber, P Schollmeyer, W H Hörl
Contributions to Nephrology|January 1, 1991
Effect of human recombinant erythropoietin on dialysis efficiency in CAPDH B Steinhauer, I Lubrich-Birkner, P Schollmeyer
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1996
Elevated lipoprotein(a) and fibrinogen levels [corrected] increase the cardiovascular risk in continuous ambulatory peritoneal dialysis patientsW Bartens, M Nauck, P Schollmeyer, et al.
Hypertension (Dallas, Tex. : 1979)|March 1, 1993
Cyclosporine and oxidized lipoproteins affect vascular reactivity. Influence of the endotheliumJ Galle, I Schenck, P Schollmeyer, et al.
Transplantation Proceedings|September 2, 1998
Drug monitoring of mycophenolic acid in the early period after renal transplantationB Krumme, K Wollenberg, G Kirste, et al.
Pageof 29